Indunil Karunarathna: Kawasaki Disease at the Intersection of Immunology, Cardiology, and Vascular Biology
Indunil Karunarathna, Founder of Uva Clinical Research Lab (UCRL), shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Kawasaki disease is a unique pediatric inflammatory disorder that occupies a critical intersection between immunology, cardiology, and vascular biology.
Although classically described as an acute, self-limited febrile illness of childhood, it is now understood to be a complex immune-mediated vasculitis with the potential for lifelong cardiovascular consequences.
The disease process is driven by dysregulated innate and adaptive immune responses that target the vascular endothelium, particularly within the coronary arteries, leading to aneurysm formation, thrombosis, and long-term vascular remodeling.
Early diagnosis and timely immunomodulatory therapy, especially intravenous immunoglobulin, dramatically reduce morbidity and mortality, transforming outcomes from historically fatal to largely survivable.
However, survival does not equate to cure.
Even in patients whose coronary aneurysms regress, persistent endothelial dysfunction and vascular scarring confer long-term cardiovascular risk.
Kawasaki disease should therefore not be conceptualized as a transient pediatric illness, but rather as a lifelong cardiovascular condition originating in childhood, requiring structured acute management, long-term surveillance, and transitional care into adulthood.”
Title: Kawasaki Disease: An Immune-Mediated Vasculopathy with Lifelong Cardiovascular Consequences
Authors: Indunil Karunarathna, Prasan Gunasena, Kap Gunawardana, Sam Rajapaksha, Palith Aluthge, Asok Jayawardana, Cam Fernando, USG Vidanagama, UPN Ekanayake, TMB Hapuarachchi, Sach Senanayaka, Ban Rathnayak, AN Thilak Warnakulasooriya, Palinda Athulgama, Mud Abeyek, San Dius, Ram Ranwala, Sanj Godage, Suni Senadeera, Jaga Wijepala, Neha Perera, Sena Gunathilake, Kap De Alvis, PNG Rodrigo
Read the Full Article on Uva Clinical Anaesthesia and Intensive Care
Other posts featuring Indunil Karunarathna on Hemostasis Today.
-
Mar 25, 2026, 15:48Micah Grey: Reflecting on an Incredible Experience at the THSNA Congress
-
Mar 25, 2026, 15:45Christi Miller: Exploring Key Facts about Hemophilia During Bleeding Disorders Awareness Month
-
Mar 25, 2026, 15:44Stéphane Laurent: Why the Relationship Between AfSBT and ISBT Matters in Blood Management
-
Mar 25, 2026, 15:36Seema Dawood: EDTA-Induced Platelet Satellitism
-
Mar 25, 2026, 15:35ABO-Incompatible Transfusions and Severe Allergic Reactions – ISBT
-
Mar 25, 2026, 15:14Critical Gaps in AF Stroke Prevention – JTH
-
Mar 25, 2026, 15:09Paul Empey: Excited to Invite You to Enjoy and Tune Into a Great NBDF Event
-
Mar 25, 2026, 15:05Allison Burnett: Antithrombosis Stewardship Is No Longer a Future Concept
-
Mar 25, 2026, 15:03Melissa Hollo: Normal Hemoglobin Does Not Exclude Severe Iron Deficiency